0001213900-20-014434.txt : 20200608
0001213900-20-014434.hdr.sgml : 20200608
20200608175915
ACCESSION NUMBER: 0001213900-20-014434
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200525
FILED AS OF DATE: 20200608
DATE AS OF CHANGE: 20200608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Luzon Ronen
CENTRAL INDEX KEY: 0001686315
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37370
FILM NUMBER: 20950290
MAIL ADDRESS:
STREET 1: 3 ARAVA ST. P.O.B 1026
CITY: AIRPORT CITY
STATE: L3
ZIP: 7010000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: My Size, Inc.
CENTRAL INDEX KEY: 0001211805
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: HAYARDEN 4
CITY: AIRPORT CITY
STATE: L3
ZIP: 7010000
BUSINESS PHONE: 972-36009030
MAIL ADDRESS:
STREET 1: HAYARDEN 4
CITY: AIRPORT CITY
STATE: L3
ZIP: 7010000
FORMER COMPANY:
FORMER CONFORMED NAME: Mysize Inc.
DATE OF NAME CHANGE: 20150317
FORMER COMPANY:
FORMER CONFORMED NAME: TOPSPIN MEDICAL INC
DATE OF NAME CHANGE: 20021226
4
1
ownership.xml
X0306
4
2020-05-25
0
0001211805
My Size, Inc.
MYSZ
0001686315
Luzon Ronen
HAYARDEN 4
AIRPORT CITY
L3
7010000
ISRAEL
1
1
0
0
Chief Executive Officer
Option to purchase Common Stock (right to buy)
18.15
2020-05-25
4
D
0
10000
D
2022-07-24
Common Stock, $.001 par value per share
10000
0
D
Option to purchase Common Stock (right to buy)
1.04
2020-05-25
4
A
0
10000
A
2023-07-24
Common Stock, $.001 par value per share
10000
10000
D
Option to purchase Common Stock (right to buy)
11.4
2020-05-25
4
D
0
6667
D
2024-05-29
Common Stock, $.001 par value per share
6667
0
D
Option to purchase Common Stock (right to buy)
1.04
2020-05-25
4
A
0
6667
A
2025-05-29
Common Stock, $.001 par value per share
6667
6667
D
Option to purchase Common Stock (right to buy)
11.4
2020-05-25
4
D
0
33334
D
2024-05-29
Common Stock, $.001 par value per share
33334
0
D
Option to purchase Common Stock (right to buy)
1.04
2020-05-25
4
A
0
33334
A
2025-05-29
Common Stock, $.001 par value per share
33334
33334
D
Option to purchase Common Stock (right to buy)
18.15
2020-05-25
4
D
0
10000
D
2022-07-24
Common Stock, $.001 par value per share
10000
0
I
See Footnote
Option to purchase Common Stock (right to buy)
1.04
2020-05-25
4
A
0
10000
A
2023-07-24
Common Stock, $.001 par value per share
10000
10000
I
See Footnote
Option to purchase Common Stock (right to buy)
11.4
2020-05-25
4
D
0
5334
D
2024-05-29
Common Stock, $.001 par value per share
5334
0
I
See Footnote
Option to purchase Common Stock (right to buy)
1.04
2020-05-25
4
A
0
5334
A
2025-05-29
Common Stock, $.001 par value per share
5334
5334
I
See Footnote
Option to purchase Common Stock (right to buy)
11.4
2020-05-25
4
D
0
17000
D
2024-05-29
Common Stock, $.001 par value per share
17000
0
I
See Footnote
Option to purchase Common Stock (right to buy)
1.04
2020-05-25
4
A
0
17000
A
2025-05-29
Common Stock, $.001 par value per share
17000
17000
I
See Footnote
Option grant under the My Size, Inc. 2017 Equity Incentive Plan, all of which have vested.
Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of July 24, 2023. All of the other terms of the option remained unchanged.
Effective May 25, 2020, the Board of Directors of the Company approved a unilateral option repricing and term extension, which resulted in the reduction of the exercise price to $1.04 per share, which is the closing price of the Company's common stock on May 22, 2020, and an expiration date of May 29, 2025. All of the other terms of the option remained unchanged.
Option grant under the My Size, Inc. 2017 Equity Incentive Plan, of which one third of the total shares vested on January 24, 2019, one third of the total shares vested on January 24, 2020 and the remaining one third of the total shares vests on January 24, 2021.
Options acquired by Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo).
On November 15, 2019, the Company implemented a 1-for-15 reverse stock split (the "Reverse Stock Split") of the Company's common stock. All amounts have been adjusted to give effect to the Reverse Stock Split.
/s/ Ronen Luzon
2020-06-08